Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: Expression in controls and downregulation in tumour tissue

Journal of Clinical Pathology - Molecular Pathology

Volumn 55, Issue 3, 2002, Pages 156-163

  Vlems, F A ^a   Diepstra, J H S ^a   Cornelissen, I M H A ^a   Ruers, T J M ^a   Ligtenberg, M J L ^a   Punt, C J A ^a   Van Krieken, J H J M ^a   Wobbes, Th ^a   Van Muijen, G N P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20; MESSENGER RNA;

ARTICLE; BLOOD ANALYSIS; BONE MARROW BIOPSY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

BONE MARROW NEOPLASMS; COLORECTAL NEOPLASMS; DOWN-REGULATION; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; QUALITY CONTROL; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0036270057     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.55.3.156     Document Type: Article

References (53)

1. Prognostic value of pathological characteristics of colorectal cancer
2. The use of prognostic markers in surgery for colorectal cancer
3. Prognostic factors in colorectal cancer
4. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors
5. The molecular deletion of circulating tumour cells
6. Molecular assessment of tumour stage and disease recurrence using PCR-based assays
7. Molecular detection of micrometastases and circulating tumor cells in solid tumors
8. Molecular detection of minimal residual disease in colorectal and breast cancer
9. Detection and clinical importance of micrometastatic disease
10. Immunocytochemical and molecular strategies for the detection of micrometastases in patients with solid epithelial tumours: A review
11. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
12. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival
13. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma
14. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR
15. Micrometastases and survival in stage II colorectal cancer
16. Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance
17. The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: Use, limitations and future of RNA-based methods
18. Detection of epithelial cancer in peripheral blood by reverse transcriptase-polymerase chain reaction
19. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease
20. Evaluation et intérêt de nouveaux marqueurs moléculaires en cancérologie colique
21. Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung
22. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction
23. CK20 gene expression: Technical limits for the detection of circulating tumor cells
24. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients
25. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes
26. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer
27. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients
28. Cytokeratin 20 in human carcinomas
29. Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer
30. Keratin 20: Immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas
31. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas
32. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: Methods, reliability, pitfalls, and solutions
33. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood
34. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow
35. Illegitimate transcription: Transcription of any gene in any cell type
36. Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity
37. Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients
38. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer ceils is influenced by cytokines in vivo and in vitro
39. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease
40. Perioperative quantitative analysis of cytokeratin 20 mRNA in peripheral venous blood of patients with colorectal adenocarcinoma
41. Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients
42. Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction
43. Genetic detection of colorectal cancer cells in circulation and lymph nodes
44. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20
45. Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics
46. Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells
47. Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: A quality-assurance initiative of the EORTC melanoma cooperative group
48. Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction
49. Primers are decisive for sensitivity of PCR
50. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: A quality control study using real-time quantitative RT-PCR
51. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction
52. Reverse transcription/polymerase chain reaction (RT/PCR) amplification of very small numbers of transcripts: The risk in misinterpreting negative results